DNLI - Denali Therapeutics Inc. Operating profit EBITDA
How can Alzheimer's and Parkinson's diseases be defeated? Absolute EBITDA captures the growth dynamics of Denali Therapeutics (DNLI), where the 0.00 level reflects the current magnitude. Prospects are based on the development of drugs that cross the blood-brain barrier. Unique drug delivery methods to the brain create monopoly potential, although the business currently relies on capital and partnership payments.
Denali Therapeutics Inc. - analytical breakdowns and key metrics (DNLI)
- share price and expert price forecast:
- market capitalization statistics:
- book value of equity indicators:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Denali Therapeutics|DNLI - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Denali|DNLI - Company Aggregate Debts|Debt to Net Assets Ratio Denali Therapeutics|DNLI - Company Long-Term Debts|Short-Term Debt Denali Therapeutics|Intermediate Coverage Ratio denalitherapeutics.com
- net income and valuation multiples indicators:
DNLI - Net Profit|Projected Future Earnings Denali Therapeutics|DNLI - Price to Earnings Ratio|Price to Expected Earnings Ratio denalitherapeutics.com|DNLI - PEG Multiple|Company Value to EBITDA Denali Therapeutics|DNLI - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Denali Therapeutics|DNLI - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months denalitherapeutics.com|DNLI - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Denali Therapeutics
Summary company analytics:Denali Corp
Denali Therapeutics (DNLI) focus on breakthrough R&D research regarding the blood-brain barrier and the development of Alzheimer's treatments defines the specifics of its cash flows. This indicator captures actual daily commercial revenue, excluding subjective assessments, which allows the company's aggregate EBITDA to differentiate short-term seasonal fluctuations from a systemic crisis in operational efficiency.
Who Denali Therapeutics competes with
BIIB: Operating profit before amortization|Neurocrine Biosciences - Operating profit EBITDA|RGC - Operating profit EBITDA|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|ACAD (ACADIA Pharma) - Profit before payment of interest, taxes and amortization|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Viking Therapeutics Corp (VKTX) - Operating income before deduction of amortization|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Harmony Biosciences Holdings, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization BHVN (Biohaven Ltd)|Amylyx - Operating profit EBITDA|Income before deduction of interest, taxes and amortization TRVI (Trevi Corp)|PRAX: Operating profit EBITDA|Profit before interest, taxes and amortization anavex.com (AVXL)|Profit before payment of interest, taxes and amortization CeriBell|PRTA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ALEC|Operating profit EBITDA Annexon Biosciences Inc. (ANNX)|Profit before payment of interest, taxes and amortization Omeros OMER|NGNE (neurogene.com) - Profit before deduction of interest, taxes, depreciation and amortization|AC Immune SA - Operating profit EBITDA|Profit before interest, taxes and amortization Voyager Therapeutics Inc|NMRA (Neumora Therapeutics Inc) - Operating profit before deduction of amortization|Scilex Holding Company, Inc. (SCLX) - Operating profit EBITDA|Operating profit before deduction of amortization TVGN|ACOG (Alpha Cognition Corp) - Company profit before taxes, interest and amortization|Operating profit EBITDA CGTX|Operating income before deduction of amortization Inhibikase Therapeutics Inc|Operating profit EBITDA SAVA (Cassava)|ASRT - Operating profit before deduction of amortization|COYA - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Vistagen Therapeutics VTGN|OVID: Operating profit EBITDA|Operating profit before amortization ABOS|Profit before payment of interest, taxes and amortization CervoMed Inc|Operating profit before amortization ATHE (Alterity Therapeutics Ltd)|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|Profit before payment of interest, taxes and amortization PEPG (pepgen.com)|Operating profit EBITDA JUNS (Jupiter Neurosciences)|Operating income before deduction of amortization Relmada Therapeutics Inc (RLMD)|ANVS - Profit before payment of interest, taxes and amortization|GRCE (Grace Therapeutics, Inc.) - Operating profit before amortization|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Operating profit before deduction of amortization NRSN|Operating profit EBITDA Reviva Pharmaceuticals Holdings Inc.|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS (NeurAxis Inc) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|Neuphoria - Operating profit EBITDA|NERV (Minerva Neurosciences Inc) - Operating profit before amortization|ATHA: Operating profit EBITDA|Profit before interest, taxes and amortization Addex (ADXN)|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Operating profit before amortization CYCN (Cyclerion)|Operating profit EBITDA PTIX|Operating profit EBITDA pasitheaclinics.com (KTTA)|Profit before payment of interest, taxes and amortization Cortigent CRGT|Avenue Therapeutics Inc - Profit before payment of interest, taxes and amortization|Brainstorm Cell - Operating profit EBITDA|Operating income before deduction of amortization caratherapeutics.com CARA|CHRO (Chromocell Therapeutics Corp.) - Operating profit before deduction of amortization|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ITCI|LBPH (Longboard) - Company profit before taxes, interest and amortization|Operating profit EBITDA MRNS|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Sage Therapeutics Inc. (SAGE) - Profit before interest, taxes and amortization|SNPX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|VIGL: Operating profit EBITDA|anewmeds.com (WENA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
